| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 70437-240-18 | 70437-240 | HUMAN PRESCRIPTION DRUG | Nerlynx | neratinib | TABLET | ORAL | 20170717 | N/A | NDA | NDA208051 | Puma Biotechnology, Inc. | NERATINIB MALEATE ANHYDROUS | 40 mg/1 | 1 BOTTLE in 1 BOX (70437-240-18) / 180 TABLET in 1 BOTTLE |
| 70437-240-26 | 70437-240 | HUMAN PRESCRIPTION DRUG | Nerlynx | neratinib | TABLET | ORAL | 20170717 | N/A | NDA | NDA208051 | Puma Biotechnology, Inc. | NERATINIB MALEATE ANHYDROUS | 40 mg/1 | 1 BOTTLE in 1 BOX (70437-240-26) / 126 TABLET in 1 BOTTLE |
| 70437-240-33 | 70437-240 | HUMAN PRESCRIPTION DRUG | Nerlynx | neratinib | TABLET | ORAL | 20170717 | N/A | NDA | NDA208051 | Puma Biotechnology, Inc. | NERATINIB MALEATE ANHYDROUS | 40 mg/1 | 1 BOTTLE in 1 BOX (70437-240-33) / 133 TABLET in 1 BOTTLE |